Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. 2015

Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. koxin-tky@umin.org.

BACKGROUND Fatty liver disease (FLD) including non-alcoholic fatty liver disease (NAFLD), a rapidly emerging and widely recognized liver disease today, is regarded as a hepatic manifestation of metabolic syndrome. Helicobacter pylori, one of the most common pathogens worldwide, has been reported to be associated with metabolic syndrome, but whether there is a direct association with FLD is as of yet unclear. The aim of this study was to clarify the association of FLD and NAFLD with causative background factors including Helicobacter pylori infection. METHODS This was a cross-sectional study of Japanese adults who received medical checkups at a single medical center in 2010.Univariate and multivariate statistical analysis was performed to evaluate background factors for ultrasonography diagnosed FLD. Subjects free from alcohol influence were similarly analyzed for NAFLD. RESULTS Of a total of 13,737 subjects, FLD was detected in 1,456 of 6,318 females (23.0 %) and 3,498 of 7,419 males (47.1%). Multivariable analyses revealed that body mass index (standardized coefficients of females and males (β-F/M) =143.5/102.5), serum ALT (β-F/M = 25.8/75.7), age (β-F/M = 34.3/17.2), and platelet count (β-F/M = 17.8/15.2) were positively associated with FLD in both genders. Of the 5,289 subjects free from alcohol influence, NAFLD was detected in 881 of 3,473 females (25.4%) and 921 of 1,816 males (50.7%). Body mass index (β-F/M = 113.3/55.3), serum ALT (β-F/M = 21.6/53.8), and platelet count (β-F/M = 13.8/11.8) were positively associated with NAFLD in both genders. Metabolic syndrome was positively associated with FLD and NAFLD only in males. In contrast, Helicobacter pylori infection status was neither associated with FLD nor NAFLD regardless of gender. CONCLUSIONS Body mass index, serum ALT and platelet count were significantly associated with FLD and NAFLD, whereas infection of Helicobacter pylori was not.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
January 2018, Frontiers in microbiology,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
January 2023, Sao Paulo medical journal = Revista paulista de medicina,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
May 2014, Journal of gastroenterology,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
March 2019, Scientific reports,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
February 2016, World journal of gastroenterology,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
August 2020, Acta dermato-venereologica,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
December 2022, Minerva medica,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
February 2022, BMC gastroenterology,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
September 2020, Minerva gastroenterologica e dietologica,
Kazuya Okushin, and Yu Takahashi, and Nobutake Yamamichi, and Takeshi Shimamoto, and Kenichiro Enooku, and Hidetaka Fujinaga, and Takeya Tsutsumi, and Yoshizumi Shintani, and Yoshiki Sakaguchi, and Satoshi Ono, and Shinya Kodashima, and Mitsuhiro Fujishiro, and Kyoji Moriya, and Hiroshi Yotsuyanagi, and Toru Mitsushima, and Kazuhiko Koike
January 2021, SAGE open medicine,
Copied contents to your clipboard!